Low-cost Imaging Technology for Global Prevention of Cervical Cancer

  • STATUS
    Recruiting
  • End date
    Dec 3, 2025
  • participants needed
    1060
  • sponsor
    Barretos Cancer Hospital
Updated on 23 October 2021
cancer
dysplasia
colposcopy
prevention of cervical cancer

Summary

Cervical cancer remains the first or second leading cause of cancer death among women in many low-and middle-income countries. Cervical cancer prevention programs in low-resource settings are hampered by a lack of personnel with appropriate clinical expertise, lack of pathology services, and lack of associated infrastructure. There is an urgent need for appropriate diagnostic tools to enable accurate screening and diagnosis in low-resource settings. The purpose of this study is to develop and validate a low-cost Multimodal Mobile Colposcope (MMC) for global cervical cancer prevention programs. This new device will combine the imaging capabilities of a mobile colposcope with the microscopic imaging capabilities of a fiber-optic confocal imaging probe.

Details
Condition cervical intraepithelial neoplasms, Cervical Intraepithelial Neoplasia
Treatment Multimodal Mobile Colposcope (MMC)
Clinical Study IdentifierNCT05078528
SponsorBarretos Cancer Hospital
Last Modified on23 October 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Women >25 years of age
Women undergoing colposcopy due to abnormal cervical screening or follow-up for a history of dysplasia
Women of childbearing potential must have a negative urine or blood pregnancy test
Ability to understand and willingness to provide informed consent by signing specific Informed Consent Document

Exclusion Criteria

Women under 25 years of age
Women who have undergone hysterectomy with removal of the cervix
Women with known allergy to proflavine or acriflavine
Women who are pregnant or nursing at the time of enrollment
Incapacitated women or in vulnerable situations or who are not willing to give consent
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note